Royal Bank Of Canada Tekla Life Sciences Investors Transaction History
Royal Bank Of Canada
- $579 Billion
- Q3 2025
A detailed history of Royal Bank Of Canada transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Royal Bank Of Canada holds 79,245 shares of HQL stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,245
Previous 451,336
82.44%
Holding current value
$1.32 Million
Previous $5.78 Million
78.74%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.39MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.59MShares$43.1 Million1.2% of portfolio
-
Morgan Stanley New York, NY871KShares$14.5 Million0.0% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.2 Million0.16% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL423KShares$7.04 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY403KShares$6.72 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...